NMPA Approval

Compound Paraceramol and Honeysuckle Irjection

Approval Number

国药准字H52020958

Registration Date

December 17, 2020

Previous Approval Numbers

国药准字H52020958

Drug Information

Generic Name

复方对乙酰氨基酚金银花注射液

Dosage Form

注射剂

Strength

2ml

Drug Type

化学药品

Registration Date

December 17, 2020

Company Address

贵州省黔南州龙里县冠山街道高新技术产业园区瑞和大健康产业园

Company Address

贵州省贵阳市白云区麦架镇新材料产业园

Empowering clinical research with data-driven insights and AI-powered tools.

复方对乙酰氨基酚金银花注射液 - NMPA 批准文号 | MedPath